๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Cost Effectiveness Analysis of Boceprevir (BOC) Added to Pegifn/Ribavirin (P/R) Versus Pegifn/Ribavirin (Current Standard of Care) for the Treatment of Patients with Genotype 1 Chronic Hepatitis C in Greece

โœ Scribed by Athanasakis, K.; Karampli, E.; Retsa, M.P.; Theodoropoulou, T.; Kyriopoulos, J.


Book ID
122709200
Publisher
John Wiley and Sons
Year
2013
Tongue
English
Weight
59 KB
Volume
16
Category
Article
ISSN
1098-3015

No coin nor oath required. For personal study only.


๐Ÿ“œ SIMILAR VOLUMES